With all the opportunistic buying from PE of beaten growers that are cash burning, it wouldn't be surprising to think these guys might be on someone's target list.
I made a reference to them in my recent article on Business Models & Valuation (link here).
They're guiding for EBIDTA positivity to be Achieved in Q1 of 24, which means they likely don't have enough cash to get to cashflow. A re-rate may still happen by purely achieving the EBITDA milestone though, given they are looking too cheap at the moment. I see a lot of potential in the future, but it remains a little risky at the moment.
DOC Price at posting:
4.3¢ Sentiment: Hold Disclosure: Not Held
